Axial reports findings of elevated 4-EPS in children with ASD
BOSTON and Pasadena, Calif., May 9, 2018 - Axial Biotherapeutics, a biotechnology company building a unique class of microbial-inspired therapeutics for neurological diseases, today announced...








